APA (7th ed.) Citation

J, R., J, H., S, H., JH, J., SB, L., TR, Y., . . . DH, M. (2024). Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 65(11), 1689. https://doi.org/10.2967/jnumed.124.267913

Chicago Style (17th ed.) Citation

J, Ryu, et al. "Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 65, no. 11 (2024): 1689. https://doi.org/10.2967/jnumed.124.267913.

MLA (9th ed.) Citation

J, Ryu, et al. "Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 65, no. 11, 2024, p. 1689, https://doi.org/10.2967/jnumed.124.267913.